No Data
Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Express News | Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Cue Biopharma to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference
Analysts Are Bullish on These Healthcare Stocks: Hookipa Pharma (HOOK), Cue Biopharma (CUE)
Cue Biopharma's Nasdaq Compliance Struggle: Risks and Implications for Future Stability
Express News | Cue Biopharma Inc : Jefferies Cuts Target Price to $4 From $6
Unlock the Full List
AddiBee0925 : Hey Jag. Just a heads up. If all goes as planned, the launch for SIDU and SpaceX is on the schedule for this Friday on the 20th. I wouldn't think that it would be rescheduled so soon to the launch, at least no report has said otherwise.
Jaguar8 OP AddiBee0925 : Yes. But there might be a build up of the price before the launch just like LUNR. Hopefully it goes well.
AddiBee0925 Jaguar8 OP : yeah I'm thinking the same
Jaguar8 OP browny_440 : TNXP will be good if FDA releases decision soon
72306783 : I would like to ask, what signals or standards do you use to start building positions? I am still learning... Thank you very much for your Share
View more comments...